101 related articles for article (PubMed ID: 7411544)
1. Retinoic acid analogues. Synthesis and potential as cancer chemopreventive agents.
Dawson MI; Hobbs PD; Kuhlmann K; Fung VA; Helmes CT; Chao WR
J Med Chem; 1980 Sep; 23(9):1013-22. PubMed ID: 7411544
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid analogues with ring modifications. Synthesis and pharmacological activity.
Dawson MI; Hobbs PD; Chan RL; Chao WR
J Med Chem; 1981 Oct; 24(10):1214-23. PubMed ID: 7328582
[TBL] [Abstract][Full Text] [Related]
3. Aromatic retinoic acid analogues. 2. Synthesis and pharmacological activity.
Dawson MI; Chan R; Hobbs PD; Chao WR; Schiff LJ
J Med Chem; 1983 Sep; 26(9):1282-93. PubMed ID: 6887203
[TBL] [Abstract][Full Text] [Related]
4. Aromatic retinoic acid analogues. Synthesis and pharmacological activity.
Dawson MI; Hobbs PD; Chan RL; Chao WR; Fung VA
J Med Chem; 1981 May; 24(5):583-92. PubMed ID: 7241516
[TBL] [Abstract][Full Text] [Related]
5. Cancer chemopreventive 3-substituted-4-oxoretinoic acids.
Shealy YF; Hosmer CA; Riordan JM; Wille JW; Rogers TS; Hill DL
J Med Chem; 1994 Sep; 37(19):3051-6. PubMed ID: 7932527
[TBL] [Abstract][Full Text] [Related]
6. Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion.
Verma AK; Shapas BG; Rice HM; Boutwell RK
Cancer Res; 1979 Feb; 39(2 Pt 1):419-25. PubMed ID: 761215
[No Abstract] [Full Text] [Related]
7. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
Verma AK; Garcia CT; Ashendel CL; Boutwell RK
Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
[TBL] [Abstract][Full Text] [Related]
8. Induction of mouse epidermal ornithine decarboxylase activity and skin tumors by 7,12-dimethylben.
Verma AK; Conrad EA; Boutwell RK
Carcinogenesis; 1980 Jul; 1(7):607-11. PubMed ID: 11219836
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumor formation by retinoic acid.
Verma AK
Cancer Res; 1988 Apr; 48(8):2168-73. PubMed ID: 3349487
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of retinol to retinoic acid as a requirement for biological activity in mouse epidermis.
Connor MJ
Cancer Res; 1988 Dec; 48(24 Pt 1):7038-40. PubMed ID: 3191479
[TBL] [Abstract][Full Text] [Related]
11. Fluorinated retinoic acids and their analogues. 1. Synthesis and Biological activity of (4-methoxy-2,3,6-trimethylphenyl)nonatetraenoic acid analogues.
Pawson BA; Chan KK; DeNoble J; Han RJ; Piermattie V; Specian AC; Srisethnil S; Trown PW; Bohoslawec O; Machlin LJ; Gabriel E
J Med Chem; 1979 Sep; 22(9):1059-67. PubMed ID: 490550
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of phorbol ester-caused synthesis of mouse epidermal ornithine decarboxylase by retinoic acid.
Verma AK
Biochim Biophys Acta; 1985 Jul; 846(1):109-19. PubMed ID: 2861859
[TBL] [Abstract][Full Text] [Related]
13. Fluorinated retinoic acids and their analogues. 3. Synthesis and biological activity of aromatic 6-fluoro analogues.
Lovey AJ; Pawson BA
J Med Chem; 1982 Jan; 25(1):71-5. PubMed ID: 7086825
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.
Verma AK; Ashendel CL; Boutwell RK
Cancer Res; 1980 Feb; 40(2):308-15. PubMed ID: 6243250
[No Abstract] [Full Text] [Related]
15. Retinoids and inhibition of ornithine decarboxylase activity.
Boutwell RK
J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):796-800. PubMed ID: 7068980
[TBL] [Abstract][Full Text] [Related]
16. Heteroarotinoids. Synthesis, characterization, and biological activity in terms of an assessment of these systems to inhibit the induction of ornithine decarboxylase activity and to induce terminal differentiation of HL-60 cells.
Spruce LW; Rajadhyaksha SN; Berlin KD; Gale JB; Miranda ET; Ford WT; Blossey EC; Verma AK; Hossain MB; van der Helm D
J Med Chem; 1987 Aug; 30(8):1474-82. PubMed ID: 3612691
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological activity of 6-[(E)-2-(2,6,6-trimethyl-1-cyclohexen-1-yl)ethen-1-yl]- and 6-(1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-naphthyl)-2-naphthalenecarboxylic acids.
Dawson MI; Chan RL; Derdzinski K; Hobbs PD; Chao WR; Schiff LJ
J Med Chem; 1983 Nov; 26(11):1653-6. PubMed ID: 6195339
[TBL] [Abstract][Full Text] [Related]
18. Dose and schedule of oral retinoic acid and indomethacin needed to effectively inhibit phorbol ester-induced epidermal ornithine decarboxylase activity.
Loprinzi CL; Verma AK
Carcinogenesis; 1985 Nov; 6(11):1589-92. PubMed ID: 4053280
[TBL] [Abstract][Full Text] [Related]
19. Vitamin A acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis.
Verma AK; Boutwell RK
Cancer Res; 1977 Jul; 37(7 Pt 1):2196-201. PubMed ID: 861945
[No Abstract] [Full Text] [Related]
20. Induction of ornithine decarboxylase activity and DNA synthesis in hairless mouse epidermis by retinoids.
Connor MJ; Lowe NJ
Cancer Res; 1983 Nov; 43(11):5174-7. PubMed ID: 6616453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
